英文名稱: | XMD17-109 |
英文別名: | XMD17-109;11-cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one;11-cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one;ERK5-IN-1;XMD17 109;11-Cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)-phenyl)amino)-5-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one |
中文別名: | 11-環(huán)戊基-2-[[2-乙氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二氫-5-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮雜卓-6-酮;XMD17-109 抑制劑 |
CAS No.: | 1435488-37-1 |
分子式: | C36H46N8O3 |
分子量: | 638.80 |
純度: | 98% |